Diagnostic Usefulness of Serum Procalcitonin in Patients with Bacterial Sepsis

Role of procalcitonin in predicting etiology in bacteremic patients: Report from a large single-center experience

(2019) Matteo Bassetti et al.   Journal of Infection and Public Health

The global burden of paediatric and neonatal sepsis: a systematic review

(2018) Carolin Fleischmann-Struzek et al.   Lancet Respiratory Medicine

The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics

(2018) Iram Yunus et al.   PLoS One

Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations

(2016) Carolin Fleischmann et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

(2016) Mervyn Singer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment

(2010) Kiran V. Sarikonda et al.   CRITICAL CARE MEDICINE

Long-term mortality and quality of life in sepsis: A systematic review*

(2010) Bradford D. Winters et al.   CRITICAL CARE MEDICINE

Procalcitonin: Uses in the Clinical Laboratory for the Diagnosis of Sepsis

(2010) Ming Jin et al.   Labmedicine

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

(2010) Lila Bouadma et al.   LANCET